Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NEDD8 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | SLC7A1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | ARRDC1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | OSGIN2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | RPL14 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | PTGIS | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | TTC39B | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | TARM1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | RNF38 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | SS18L1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |